All Reports Events Blogs Videos
Showing 56 results
  • Accelerator
    Jan. 07, 2026

    Procurement organizations prioritize reducing costs, managing risks, and creating business value. Category management helps achieve these goals by optimizing category spend, identifying cost-saving opportunities, and improving operational efficiency. This report equips data and analytics service buyers…
  • Provider Compendium
    Nov. 28, 2025

    Everest Group’s Order-to-Cash (O2C) Products – Provider Compendium 2025 provides comprehensive and fact-based snapshots of 16 O2C products and includes insights on the global O2C products market. It examines each product’s features, enhancements, and market adoption…
  • PEAK Matrix®
    June 23, 2026

    Healthcare payers are accelerating digital transformation initiatives in response to rising medical loss ratios, increasing interoperability mandates, and growing demand for personalized member engagement. To address these priorities, enterprises are focusing on care management and member…
  • PEAK Matrix®
    Sep. 30, 2025

    Enterprises are increasingly turning to modern Order-to-Cash (O2C) products in response to growing cost pressures, tighter regulations, and the need for improved agility. Once viewed as a back-office finance function, O2C is becoming a strategic enabler…
  • State of the Market
    Feb. 25, 2026

    The clinical development technology market transform as life sciences enterprises increasingly rely on digital and AI-enabled solutions to manage rising costs, complex regulatory demands, and longer development cycles. This State of the Market report outlines how…
  • PEAK Matrix®
    June 04, 2025

    Healthcare enterprises are increasingly recognizing the strategic value of Data, Analytics, and AI (DAAI) as data-driven decision-making becomes central to achieving business and clinical outcomes. While DAAI initiatives have traditionally focused on cost containment and operational…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • PEAK Matrix®
    Aug. 26, 2026

    Order-to-Cash (O2C) is moving higher on the CFO agenda as enterprises seek to improve cash predictability, support evolving monetization models, and meet rising expectations for seamless stakeholder experiences. These priorities are accelerating demand for O2C products…
  • PEAK Matrix®
    Aug. 19, 2025

    Clinical Data Management (CDM) is rapidly transforming as life sciences enterprises navigate increasing trial complexity, heightened regulatory scrutiny, and the expansion of decentralized and real-world data sources. CDM now plays a strategic role in enabling faster,…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are redefining their Data and Analytics (D&A) strategies to build a strong data foundation for AI that is tailored to their unique business context. This shift reflects a move from broad transformation programs to focused…
  • Provider Compendium
    Feb. 20, 2025

    Enterprises are increasingly recognizing their data ecosystem gaps as they strive to fully harness generative AI’s potential. Consequently, they are prioritizing AI-ready data ecosystems, emphasizing robust data management and governance. When scaling their AI initiatives, they…
  • Provider Compendium
    Feb. 28, 2025

    Decentralized and hybrid designs add more complexity to clinical trials, generating vast data volumes from diverse sources. This complexity creates significant data management challenges. In response, sponsors are adopting unified clinical Data and Analytics (D&A) platforms…
  • PEAK Matrix®
    Dec. 06, 2024

    Enterprises are increasingly recognizing gaps in their data ecosystems as they strive to fully harness gen AI’s potential. Businesses are prioritizing AI-ready data ecosystems, emphasizing robust data management and governance. When scaling their AI initiatives, they…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Provider Compendium
    Nov. 06, 2025

    Clinical Data Management (CDM) operations have become a strategic priority for life sciences enterprises as they face growing trial complexities, expanding data volumes, and the integration of decentralized and real-world data sources. These dynamics are reshaping…
  • PEAK Matrix®
    Sep. 06, 2024

    Data, Analytics, and AI (DAAI) services are transforming Retail and Consumer Packaged Goods (RCPG) enterprises by enhancing operations and improving customer experiences. Data services integrate and manage data from various sources, ensuring accuracy and security, while…
  • Tech Provider Spotlight
    Nov. 21, 2025

    As macroeconomic challenges such as inflation and tariff volatility persist, Revenue Growth Management (RGM) has become a strategic priority for retail and CPG enterprises seeking sharper execution and sustainable profitability. Once a tactical function, RGM is…
  • Provider Compendium
    Nov. 30, 2023

    Enterprises currently face the challenge of harmonizing value realization and experimentation in their Data and Analytics (D&A) investments amid prevailing macroeconomic conditions. They are striving to attain RoI and tangible business outcomes from their D&A initiatives.…
  • PEAK Matrix®
    Sep. 12, 2023

    Enterprises are struggling to strike the right balance between value realization and experimentation through their Data and Analytics (D&A) investments amid the macroeconomic conditions. They are prioritizing RoI and direct business outcomes from D&A initiatives. At…

Items per page